-+ 0.00%
-+ 0.00%
-+ 0.00%

BATTELLE: CO & CMC PHARMACEUTICALS AWARDED $40 MLN FIVE-YEAR ARDAP PROGRAM BY U.S. DOW CONTRACT TO DEVELOP NERVE AGENT COUNTERMEASURES

Reuters·10/14/2026 18:53:05